phenyl acetate has been researched along with yttrium radioisotopes in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson-Berg, WT; Squire, RA; Strand, M | 1 |
| Chaovapong, W; Goodwin, DA; Greiner, DP; Kronenberger, SI; Kukis, DL; McTigue, M; Meares, CF; Ransone, CM; Renn, O; Watanabe, N | 1 |
| DUDLEY, HC; GREENBERG, J | 1 |
| Chakraborty, S; Chakravarty, R; Dash, A | 1 |
4 other study(ies) available for phenyl acetate and yttrium radioisotopes
| Article | Year |
|---|---|
Specific radioimmunotherapy using 90Y-labeled monoclonal antibody in erythroleukemic mice.
Topics: Acetates; Acetic Acid; Animals; Antibodies, Monoclonal; Immunotherapy; Leukemia, Erythroblastic, Acute; Leukemia, Experimental; Mice; Tissue Distribution; Yttrium; Yttrium Radioisotopes | 1987 |
Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy.
Topics: Acetates; Animals; Antibodies, Monoclonal; Half-Life; Heterocyclic Compounds; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Radioimmunotherapy; Tissue Distribution; Yttrium Radioisotopes | 1994 |
Influence of chelates on the metabolism of radioyttrium (Y90). II.
Topics: Acetates; Chelating Agents; Radioactivity; Yttrium; Yttrium Radioisotopes | 1956 |
A systematic comparative evaluation of 90Y-labeled bifunctional chelators for their use in targeted therapy.
Topics: Acetates; Animals; Bridged Bicyclo Compounds, Heterocyclic; Chelating Agents; Humans; Mice; Pentetic Acid; Radiopharmaceuticals; Yttrium Radioisotopes | 2014 |